Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Chickenpox

Download as doc
Download as doc
You are on page 1of 3

A Pox with a One-Two Punch

It began as a slight itch in the center of my back. After a few days, a small red rash

appeared and the itch became harder to ignore. I had one or two basal cell carcinomas removed

in the recent past and I wondered if this might be something similar. I went to my doctor to find

out. One look at the little rash above my spine and she said, “Shingles.”

Shingles? My grandmother sometimes would complain about those. How could I have

an aliment most people associated with being old? I’m not that old. Really. But I did have

chickenpox as a child and that long-forgotten illness had come back to haunt me as shingles.

Chickenpox, or varicella, is a common childhood infection caused by varicella zoster

virus (VZV). Chickenpox is extremely contagious, but the disease is usually mild. The virus is

spread by close contact, droplets and respiratory aerosols. It produces fever, malaise, and

hundreds of itchy, fluid-filled skin blisters. The blisters (pox) eventually burst and crust over

and the unfortunate child is no longer contagious. This childhood illness is such a right of

passage that parents have been known to hold “pox parties” in order to expose their children and

get the infection over with early in life.

Despite pox parties, chickenpox is not an entirely benign infection. Each year an

estimated four million cases lead to lost school and work time, 11,000 hospitalizations, and some

deaths. Eight adults and children died in the U.S. from chickenpox during 2003 and 2004.

There was not much anyone could do about chickenpox until the Food and Drug

Administration (FDA) approved a vaccine called Varivax in 1995. The federal Advisory

Committee on Immunization Practices quickly recommended it for all children. The vaccine

consists of a weakened form of VZV and is given in one or two doses depending on the age of

the child.

1
Many states now require the vaccine, or proof of prior chickenpox, for all students

entering the school system. Maryland, for example, requires chickenpox vaccination or proof of

prior infection for all students entering public schools and pre-school programs

(www.aahealth.org).

Do we really need another mandatory vaccine, especially one for a disease that is so mild

and causes so few deaths? Good question. Besides, once a person has had chickenpox they

usually have life-long immunity against it. But the chickenpox virus is a strange virus. Even

after you get over it and develop immunity, you still never really get rid of the virus. And that

brings me back to my case of shingles.

After a chickenpox infection the virus goes into hiding. Unfortunately, it usually hides

within sensory nerve cells near the spinal cord. Then as you and your immune system age the

virus reappears. It multiples, causing pain and itching, and damages the nerve cells. A blistering

rash appears in the same area of the skin. This rash is called shingles or herpes zoster.

The pain from shingles can be quite severe and can persist for weeks or months. People

with shingles are also contagious to those who have not had chickenpox or been vaccinated.

Treatment for shingles consists of oral antiviral drugs such as acyclovir, famciclovir and

valaciclovir. These drugs help to control the pain and reduce the chances of spreading the

infection to others. The chickenpox vaccine is intended to prevent chickenpox in childhood, but

it also has the added benefit of preventing shingles later on in life.

What about those of us who had chickenpox as kids and are now adults walking around

with dormant chickenpox virus waiting to re-appear as shingles? Running to the doctor is the

only current opinion, but a new vaccine could help to combat the painful blistering of shingles.

2
An experimental shingles vaccine has been tested in adults and found to prevent about

fifty percent of shingles cases. The vaccine (Zostavax) consists of a single injection of a

weakened form of the varicella-zoster virus. In addition to reducing the incidence of shingles,

the vaccine also reduced the severity of shingles.

It could be a very popular vaccine among middle-aged adults and the elderly. If it gets

approved by the FDA. The regulatory agency was supposed to make a decision by February 23,

but a new deadline has been set for May 25. It’s unclear what led to the delay, but one health

care analyst recently told the Associated Press the FDA is “bordering on being dysfunctional”

due to staffing and political problems. Or maybe no one on the FDA advisory panel has ever had

shingles.

You might also like